Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5d1de0cb099ee72980dadb3b90d66d8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-918 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-927 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-56 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-56 |
filingDate |
2001-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78f1df92b739b48cbc8427a51cab6d29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ecbf82c122046a5cae2723f8bf19117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df55aabc02c3cea57284c24ac9def11d |
publicationDate |
2002-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2002168378-A1 |
titleOfInvention |
Murine interferon-alpha |
abstract |
Interferons represent an important class of biopharmaceutical products, which have a proven track record in the treatment of a variety of medical conditions, including the treatment of certain autoimmune diseases, the treatment of particular cancers, and the enhancement of the immune response against infectious agents. The present invention provides a new form of murine interferon-α, which has applications in diagnosis and therapy. |
priorityDate |
1999-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |